Trial
NCT00886782
A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bristol-Myers Squibb
Collaborators
Exelixis
Condition
Advanced Solid Cancers
Intervention
Cdc7-inhibitor
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-28